| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.62B | +12.4% |
| R&D Expense | $7.5M | +1.9% |
| Pre-tax Income | $612.7M | +14.6% |
| Income Tax | $133.3M | +15.7% |
| Net Income | $479.4M | +14.3% |
| EPS (Basic) | $5.05 | +12.0% |
| EPS (Diluted) | $5.05 | +12.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.97B | +330.3% |
| Total Assets | $39.57B | +2.6% |
| Total Liabilities | $32.13B | +2.1% |
| Stockholders' Equity | $7.44B | +5.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $472.7M | -26.9% |
| Capital Expenditures | $21.1M | -38.1% |
| Investing Cash Flow | $1.98B | +81.1% |
| Financing Cash Flow | -$940.2M | +44.9% |
| Free Cash Flow | $451.6M | -26.2% |